Skip to main content

Advertisement

Log in

Esophagus or Stomach? The Seventh TNM Classification for Siewert Type II/III Junctional Adenocarcinoma

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The aim of this study is to clarify whether TNM-EC or TNM-GC is better for classifying patients with AEG types II/III.

Methods

The patients who had AEG types II/III and received D1 or more radical lymphadenectomy were selected. The patients were staged both by seventh edition of TNM-EC and TNM-GC. The distribution of the patients, the hazard ratio (HR) of each stage, and the separation of the survival were compared.

Results

A total of 163 patients were enrolled in this study. TNM-EC and TNM-GC classified 25 (20 and 5) and 32 (20 and 12) patients to stage I (IA and IB), 15 (4 and 11), and 33 (11 and 22) to stage II (IIA and IIB), 88 (24, 3, and 61) and 63 (14, 26, and 23) to stage III (IIIA, IIIB, and IIIC), and 35 and 35 to stage IV, respectively. The distribution of the patients was substantially deviated to stage IIIC in TNM-EC but was almost even in TNM-GC. A stepwise increase of HR was observed in TNM-GC, but not in TNM-EC. The survival curves between stages II and III were significantly separated in TNM-GC (P = 0.019), but not in TNM-EC (P = 0.204). The 5-year survival rates of stages IIIA, IIIB, and IIIC were 69.0, 100, and 38.9 % in TNM-EC and were 52.0, 43.4, and 33.9 % in TNM-GC, respectively.

Conclusions

TNM-GC is better for classifying patients with AEG types II/III than TNM-EC is. These results could impact the next TNM revision for AEG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–2053.

    Article  PubMed  CAS  Google Scholar 

  2. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287–1289.

    Article  PubMed  CAS  Google Scholar 

  3. Hansen S, Wiig JN, Giercksky KE, Tretli S. Esophageal and gastric carcinoma in Norway 1958–1992: incidence time trend variability according to morphological subtypes and organ subtypes. Int J Cancer. 1997;71:340–344.

    Article  PubMed  CAS  Google Scholar 

  4. Pera M, Manterola C, Grande L. Epidemiology of esophageal adenocarcinoma. J Surg Oncol. 2005;92:151–159.

    Article  PubMed  Google Scholar 

  5. Lerut T, Decker G, Coosemans W, De Leyn P, Decaluwé H, Nafteux P, et al. Quality indicators of surgery for adenocarcinoma of the esophagus and gastroesophageal junction. Recent Results Cancer Res. 2010;182:127–142.

    Article  PubMed  Google Scholar 

  6. Blaster MJ, Saito D. Trends in reported adenocarcinomas of the oesophagus and gastric cardia in Japan. Eur J Gastroenterol Hepatol. 2002;14;107–113.

    Article  Google Scholar 

  7. Kusano C, Gotoda T, Khor CJ, Katai H, Kato H, Taniguchi H, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large referral center in Japan. J Gastroenterol Hepatol. 2008;23:1662–1665.

    Article  PubMed  Google Scholar 

  8. UICC. Oesophagus including oesophagogastric junction. In: Sobin LH, Gospodarowicz M, Wittekind C, editors. TNM Classification of Malignant Tumours. 7th ed. New York: Wiley; 2009:66–72.

  9. Gertler R, Stein HJ, Loos M, Langer R, Friess H, Feith M. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer? Am J Surg Pathol. 2011;35:1512–1522.

    Article  PubMed  Google Scholar 

  10. Siewert JR, Stein HJ. Carcinoma of the cardia: carcinoma of the gastroesophageal junction-classification, pathology and extent of resection. Dis Esoph. 1996;9:173–182.

    Google Scholar 

  11. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85:1457–1459.

    Article  PubMed  CAS  Google Scholar 

  12. Wittekind CH, Greene FL, Hutter RVP, Sobin LH, Henson DE, et al. TNM supplement: a commentary on uniform use. 3rd ed. Wiley:New York; 2003.

    Google Scholar 

  13. Hasegawa S, Yoshikawa T. Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Gastric Cancer. 2010;13:63–73.

    Article  PubMed  Google Scholar 

  14. Hasegawa S, Yoshikawa T, Cho H, Tsuburaya A, Kobayashi O. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center. World J Surg. 2009;33:95–103.

    Article  PubMed  Google Scholar 

  15. Siewert JR, Stein HJ, Feith M. Adenocarcinoma of the esophagogastric junction. Scand J Surg. 2006;95:260–269.

    PubMed  CAS  Google Scholar 

  16. Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol. 2005;90:139–146.

    Article  PubMed  Google Scholar 

  17. de Manzoni G, Pedrazzani C, Pasini F, Di Leo A, Durante E, Castaldini G, et al. Results of surgical treatment of adenocarcinoma of the gastric cardia. Ann Thorac Surg. 2002;73:1035–1040.

    Article  PubMed  Google Scholar 

  18. Bai JG, Lv Y, Dang CX. Adenocarcinoma of the esophagogastric junction in China according to Siewert’s classification. Jpn J Clin Oncol. 2006;36:364–367.

    Article  PubMed  Google Scholar 

  19. Suh YS, Han DS, Kong SH, Lee HJ, Kim YT, Kim WH, et al. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification. Ann Surg. 2012;255:908–915.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takaki Yoshikawa MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hasegawa, S., Yoshikawa, T., Aoyama, T. et al. Esophagus or Stomach? The Seventh TNM Classification for Siewert Type II/III Junctional Adenocarcinoma. Ann Surg Oncol 20, 773–779 (2013). https://doi.org/10.1245/s10434-012-2780-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-012-2780-x

Keywords

Navigation